KZA kazia therapeutics limited

Nasdaq 21/4, page-2

  1. 13,336 Posts.
    lightbulb Created with Sketch. 95
    It may go down 30-40% but will not close down to 40%. Novogen is now cashed up with two great potentials drugs on table that could make a hisotry if succcessful. Nasdaq act lot differently than ASX where global cashed up investors looking for a junior bio like Novogen that can bring great return in medium-long term. This will be soaked up at such a great discounted price.

    Cheer
    J
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.